Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Accumulated Depreciation (2018 - 2019)

X4 Pharmaceuticals' Accumulated Depreciation history spans 2 years, with the latest figure at $305000.0 for Q2 2019.

  • For Q2 2019, Accumulated Depreciation changed N/A year-over-year to $305000.0; the TTM value through Jun 2019 reached $305000.0, changed N/A, while the annual FY2018 figure was $176000.0, N/A changed from the prior year.
  • Accumulated Depreciation reached $305000.0 in Q2 2019 per XFOR's latest filing, up from $177000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $2.3 million in Q1 2018 to a low of $176000.0 in Q4 2018.